312 related articles for article (PubMed ID: 15516832)
1. Withaferin A is a potent inhibitor of angiogenesis.
Mohan R; Hammers HJ; Bargagna-Mohan P; Zhan XH; Herbstritt CJ; Ruiz A; Zhang L; Hanson AD; Conner BP; Rougas J; Pribluda VS
Angiogenesis; 2004; 7(2):115-22. PubMed ID: 15516832
[TBL] [Abstract][Full Text] [Related]
2. Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization.
Bargagna-Mohan P; Ravindranath PP; Mohan R
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4138-45. PubMed ID: 16936134
[TBL] [Abstract][Full Text] [Related]
3. Development of withaferin A analogs as probes of angiogenesis.
Yokota Y; Bargagna-Mohan P; Ravindranath PP; Kim KB; Mohan R
Bioorg Med Chem Lett; 2006 May; 16(10):2603-7. PubMed ID: 16513346
[TBL] [Abstract][Full Text] [Related]
4. Molecular insight in the multifunctional activities of Withaferin A.
Vanden Berghe W; Sabbe L; Kaileh M; Haegeman G; Heyninck K
Biochem Pharmacol; 2012 Nov; 84(10):1282-91. PubMed ID: 22981382
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
6. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".
Yang H; Shi G; Dou QP
Mol Pharmacol; 2007 Feb; 71(2):426-37. PubMed ID: 17093135
[TBL] [Abstract][Full Text] [Related]
7. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
[TBL] [Abstract][Full Text] [Related]
8. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Fan Y; Peng A; He S; Shao X; Nie C; Chen L
J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
[TBL] [Abstract][Full Text] [Related]
9. Withaferin A: a new radiosensitizer from the Indian medicinal plant Withania somnifera.
Devi PU; Akagi K; Ostapenko V; Tanaka Y; Sugahara T
Int J Radiat Biol; 1996 Feb; 69(2):193-7. PubMed ID: 8609455
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation.
Oh JH; Lee TJ; Kim SH; Choi YH; Lee SH; Lee JM; Kim YH; Park JW; Kwon TK
Apoptosis; 2008 Dec; 13(12):1494-504. PubMed ID: 19002588
[TBL] [Abstract][Full Text] [Related]
11. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
[TBL] [Abstract][Full Text] [Related]
12. Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization.
Devi PU
Indian J Exp Biol; 1996 Oct; 34(10):927-32. PubMed ID: 9055640
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
Morais C; Gobe G; Johnson DW; Healy H
Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves.
Jayaprakasam B; Zhang Y; Seeram NP; Nair MG
Life Sci; 2003 Nov; 74(1):125-32. PubMed ID: 14575818
[TBL] [Abstract][Full Text] [Related]
18. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
19. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
20. Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.
Kaileh M; Vanden Berghe W; Heyerick A; Horion J; Piette J; Libert C; De Keukeleire D; Essawi T; Haegeman G
J Biol Chem; 2007 Feb; 282(7):4253-4264. PubMed ID: 17150968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
